본문 바로가기
KERD
논문KCI 등재

Nitric Oxide in Psychiatry

1

조회

0

다운로드

0

인용

0

참고문헌

초록

Nitric oxide (NO) is an important molecule, and was named“molecule of the year” by the journal Science in 1992. NO plays a pivotal role in physiological and pathological processes in the brain. There is no doubt that excitability and neurotransmitter release are modulated by NO in the brain. The effects of NO are mediated primarily by cGMP and glutamate. The NO-cGMP system is required for activity-dependent synaptic plasticity in various brain regions, including the hippocampus, amygdala, striatum, cerebral cortex, and cerebellum. There appear to be mechanisms that limit the excitatory effects of the NO-cGMP system, such as inhibition of NMDA receptor responses or enhancing the release of GABA. NO participates in a wide range of physiological activities, ranging from regulation of blood pressure to processes underlying some forms of learning and memory. NO is not a specific marker of disease, because its widespread role in cell metabolism could suggest its involvement in many disorders. The wide spectrum of NO-associated psychiatric disorders includes neurodegenerative diseases, such as Alzheimer’s disease, as well as schizophrenia and mood and eating disorders. Agents intended to intervene in the NO pathway may provide a new approach to the treatment of certain neuropsychiatric disorders, including schizophrenia, mood and eating disorders, and neurodegenerative diseases.

Abstract

Nitric oxide (NO) is an important molecule, and was named“molecule of the year” by the journal Science in 1992. NO plays a pivotal role in physiological and pathological processes in the brain. There is no doubt that excitability and neurotransmitter release are modulated by NO in the brain. The effects of NO are mediated primarily by cGMP and glutamate. The NO-cGMP system is required for activity-dependent synaptic plasticity in various brain regions, including the hippocampus, amygdala, striatum, cerebral cortex, and cerebellum. There appear to be mechanisms that limit the excitatory effects of the NO-cGMP system, such as inhibition of NMDA receptor responses or enhancing the release of GABA. NO participates in a wide range of physiological activities, ranging from regulation of blood pressure to processes underlying some forms of learning and memory. NO is not a specific marker of disease, because its widespread role in cell metabolism could suggest its involvement in many disorders. The wide spectrum of NO-associated psychiatric disorders includes neurodegenerative diseases, such as Alzheimer’s disease, as well as schizophrenia and mood and eating disorders. Agents intended to intervene in the NO pathway may provide a new approach to the treatment of certain neuropsychiatric disorders, including schizophrenia, mood and eating disorders, and neurodegenerative diseases.

참고문헌 (93)

  1. Ignarro LJ, "Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide", Proc Natl Acad Sci USA, 84, pp.9265~9269 (1987)
  2. Palmer RM, "Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor", Nature, 327, pp.524~526 (1987)
  3. Bredt DS, "Nitric oxide: a physiological messenger molecule", Annu Rev Biochem, 63, pp.175~195 (1994)
  4. Paul V, "A role of nitric oxide as an inhibitor of gamma-aminobutyric acid transaminase in rat brain", Brain Res Bull, 51, pp.43~46 (2000)
  5. Schuman EM, "Nitric oxide and synaptic function", Annu Rev Neurosci, 17, pp.153~183 (1994)
  6. Sperlagh B, "ATP released by LPS increases nitric oxide production in raw 264.7 macrophage cell line via P2Z", P2X7 receptors, 1998, pp.33, 209~215
  7. Garthwaite J, "Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intracellular messenger in the brain", Nature, 336, pp.385~388 (1988)
  8. Snyder SH, "Nitric oxide as a neuronal messenger", Trends Pharmacol Sci, 12, pp.125~128 (1991)
  9. Brenman FE, "Synaptic signaling by nitric oxide", Curr Opin Neurobiol, 7, pp.374~378 (1997)
  10. Szabo C, "Physiological and pathophysiological roles of nitric oxide in the central nervous system", Brain Res Bull, 41, pp.131~141 (1996)
  11. Okada D, "Distinct glutamate receptors govern differential levels of nitric oxide production in a layer-specific manner in the rat cerebellar cortex", Neuroscience, 125, pp.461~472 (2004)
  12. Kiss JP, "Nitric oxide: a novel link between synaptic and nonsynaptic transmission", Trends Neurosci, 24, pp.211~215 (2001)
  13. dopamine uptake, "Brain Res", 1994, 83~91
  14. Boehning D, "Novel neural modulators", Annu Rev Neurosci, 26, pp.105~131 (2003)
  15. Pepicelli O, "GABA (A), but not NMDA, receptor modulate in vivo NO-mediated cGMP synthesis in rat cerebral cortex", Neuropharmacology, 46, pp.480~489 (2004)
  16. Moro MA, "Role of nitric oxide after brain ischemia", Cell Calcium, 36, pp.265~275 (2004)
  17. Dawson TM, "Gases as biological messengers: nitric oxide and carbon monoxide in the brain", J Neurosci, 14, pp.5147~5159 (1994)
  18. Forstermann U, "Nitric oxide synthase: expression and expressional control of the three isoforms", Naunyn-Schmiedeberg’s Arch Pharmacol, 352, pp.351~364 (1995)
  19. Myers RD, "Simultaneous comparison of cerebral dialysis and push-pull perfusion in the brain of rats: a critical review", Neurosci Biobehav Res, 22, pp.371~387 (1998)
  20. Murad F, "The role of nitric oxide in modulating guanylyl cyclase", Neurotransmission, 10, pp.1~4 (1994)
  21. Lipton SA, "A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds", Nature, 364, pp.626~632 (1993)
  22. Salvemini D, "Nitric oxide activates cyclooxygenase enzymes", Proc Natl Acad Sci USA, 통권 : 90, pp.7240~7244 (1993)
  23. Henry Y, "EPR characterization of molecular targets for NO in mammalian cells and organelles", FASEB J, 7, pp.1124~1134 (1993)
  24. Beckman JS, "Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide", Proc Natl Acad Sci USA, 통권 : 87, pp.1620~1624 (1990)
  25. Beckman JS, "The double-edged role of nitric oxide in brain function and superoxide-mediated injury", J Dev Physiol, 15, pp.53~59 (1991)
  26. Radi R, "Peroxynitriteinduced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide", Arch Biochem Biophys, 288, pp.481~487 (1991)
  27. Wang X, "Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system", L Neurochem, 68, pp.443~456 (1997)
  28. Smolenski A, "Functional analysis of cGMP-dependent protein kinases I and II as mediators of NO", cGMP effects, 1998, pp.358, 134~139
  29. Erdemmli G, "Nitric oxide tonically depresses a voltage- and Ca-dependent outward current in hippocampal slices", Neurosci Lett, 201, pp.57~60 (1995)
  30. Pineda J, "Nitric oxide and carbon monoxide activate locus ceruleus neurons through a cGMPdependent protein kinase: involvement of a nonselective cationic channel", J Neurosci, 16, pp.1389~1399 (1996)
  31. Zarri I, "Modulation by nitric oxide of rat brain GABAA receptors", Neurosci Lett, 180, pp.239~242 (1994)
  32. Robello M, "Nitric oxide and GABAA receptor function in the rat cerebral cortex and cerebellar granule cells", Neuroscience, 74, pp.99~105 (1996)
  33. Dev KK, "Modulation of α-amino-3hydroxy-5-methylisoxazole- 4-propionic acid (AMPA) binding sites by nitric oxide", J Neurochem, 63, pp.946~952 (1994)
  34. Lei SZ, "Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex", Neuron, 8, pp.1087~1099 (1992)
  35. Prast H, "Nitric oxide-induced release of acetylcholine in the nucleus accumbens: role of cGMP, glutamate and GABA", J Neurochem, 71, pp.266~273 (1998)
  36. Lawrens AJ, "Nitric oxide increases interstitial excitatory amino acid release in the rat dorsomedial medulla oblongata", Neurosci Lett, 151, pp.126~129 (1993)
  37. Sorkin LS, "NMDA evokes an L-NAME sensitive spinal release of glutamate and citrulline", Neuroreport, 4, pp.479~482 (1993)
  38. Horn T, "Nitric oxide actions in paraventricular nucleus: cardiovascular and neurochemical implications", Am J Physiol, 26, pp.R306~R313 (1994)
  39. Segovia G, "Effects of a nitric oxide donor on glutamate and GABA release in striatum and hippocampus of the conscious rat", Neuroreport, 5, pp.1937~1940 (1994)
  40. Segieth J, "Nitric oxide regulates excitatory amino acid release in a biphasic manner in freely moving rats", Neurosci Lett, 200, pp.101~104 (1995)
  41. Prast H, "Nitric oxide influences the release of histamine and glutamate in the rat hypothalamus", Naunyn Schmiedebergs Arch Pharmacol, 354, pp.731~735 (1996)
  42. Bogdanov MB, "Possible involvement of nitric oxide in NMDA-induced glutamate release in the rat striatum: an in vivo microdialysis study", Neurosci Lett, 221, pp.197~201 (1997)
  43. Sequeira SM, "Carvalho AP, Carvalho CM. Modulation of glutamate release from rat hippocampal synaptosomes by nitric oxide", Nitric Oxide, 1, pp.315~329 (1997)
  44. Larkman AU, "Synaptic plasticity: hippocampal LTP", Curr Opin Neurobiol, 5, pp.324~334 (1995)
  45. Guevara-Guzman R, "Modulation of in vivo striatal transmitter release by nitric oxide and cGMP", J Neurochem, 62, pp.807~810 (1994)
  46. Getting SJ, "Biphasic modulation of GABA release by nitric oxide in the hippocampus of freely moving rats in vivo", Brain Res, 717, pp.196~199 (1996)
  47. Prast H, "Nitric oxide releases acetylcholine in the basal forebrain", Eur J Pharmacol, 216, pp.139~140 (1992)
  48. Prast H, "Nitric oxide modulates the release of acetylcholine in the ventral striatum of the freely moving rats", Naunyn-Schmiedeberg's Arch Pharmacol, 352, pp.67~72 (1995)
  49. Zhu XZ, "Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices", J Neurochem, 59, pp.932~935 (1992)
  50. West AR, "Nitric oxide and potassium chloridefacilitated striatal dopamine efflux in vivo: role of calcium-dependent release mechanisms", Neurochem Int, 33, pp.493~501 (1998)
  51. Lorrain DS, "Nitric oxide increases dopamine and serotonin release in the medial preoptic area", Neuroreport, 5, pp.87~89 (1993)
  52. Strasser A, "Stanimirovic D, Spatz M. L-arginine induces dopamine release from the striatum in vivo", Neuroreport, 5, pp.2298~2300 (1994)
  53. Lorrain DS, "Nitric oxide promotes medial preoptic dopamine release during male rat copulation", Neuroreport, 8, pp.31~34 (1996)
  54. Ohno M, "N-methyl-D-aspartate stimulates dopamine release through nitric oxide formation in the nucleus accumbens of rats", Brain Res, 699, pp.332~335 (1995)
  55. Lonart G, "Nitric oxide induces neurotransmitter release from hippocampal slices", Eur J Pharmacol, 220, pp.271~272 (1992)
  56. Satoh S, "NO donors stimulate noradrenaline release from rat hippocampus in a calmodulin-dependent manner in the presence of L-cysteine", L Cell Physiol, 169, pp.87~96 (1996)
  57. Satoh S, "Involvement of L-type-like amino acid transporters in Snitrosocysteine- stimulated noradrenaline release in the rat hippocampus", J Neurochem, 69, pp.2197~2205 (1997)
  58. Kaehler ST, "Nitric oxide modulates the release of serotonin in the rat hypothalamus", Brain Res, 835, pp.346~349 (1999)
  59. Kendrick KM, "NMDA and kainite-evoked release of nitric oxide and classical transmitters in the rat striatum: in vivo evidence that nitric oxide may play a neuroprotective role", Eur J Neurosci, 8, pp.2619~2634 (1996)
  60. O’Dell TJ, "Tests of the roles of the two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger", Proc Natl Acad Sci USA, 통권 : 88, pp.11285~11289 (1991)
  61. Schuman EM, "A requirement for the intercellular messenger nitric oxide in long-term potentiation", Science, 254, pp.1503~1506 (1991)
  62. Zhou M, "Nitric oxide and carbon monoxide produce activity-dependent long-term synaptic enhancement in hippocampus", Science, 260, pp.1946~1950 (1993)
  63. Schuman EM, "Locally distributed synaptic potentiation in the hippocampus", Science, 263, pp.532~536 (1994)
  64. Aizenman E, "Selective modulation of NMDA responses by reduction and oxidation", Neuron, 2, pp.1257~1263 (1989)
  65. Dawson VL, "Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures", Proc Natl Acad Sci USA, 통권 : 88, pp.6368~6371 (1991)
  66. Akbarian S, "Altered distribution of nicotinamideadenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development", Arch Gen Psychiatry, 50, pp.169~177 (1993)
  67. Akbarian S, "Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development", Arch Gen Psychiatry, 50, pp.178~186 (1993)
  68. Downen M, "Neuronal nitric oxide synthase expression in developing and adult human brain", J Neuropathol Exp Neurol, 58, pp.12~21 (1999)
  69. Gibbs SM, "Regulation of neuronal proliferation and differentiation by nitric oxide", Mol Neurosci, 27, pp.107~120 (2003)
  70. Mantelas A, "Control of neuronal nitric oxide synthase and brainderived neurotrophic factor levels by GABA-A receptors in developing rat cortex", Dev Brain Res, 145, pp.185~195 (2003)
  71. McQuillen PS, "Selective vulnerability in the developing central nervous system", Pediatr Neurol, 30, pp.227~235 (2004)
  72. Xing G, "Decreased calcium-dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression", Schizophr Res, 58, pp.21~30 (2002)
  73. Das I, "Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production", Neurosci Lett, 215, pp.203~211 (1996)
  74. Taneli F, "Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia", Arch Med Res, 35, pp.401~405 (2004)
  75. Srivastava N, "Nitrite content and antioxidant enzyme levels in the blood of schizophrenic patients", Psychopharmacology, 158, pp.140~145 (2001)
  76. Suzuki E, "Plasma nitrate levels in deficit versus non-deficit forms of schizophrenia", J Psychiatr Neurosci, 28, pp.288~292 (2003)
  77. Iwahashi K, "Haloperidol inhibits neuronal nitric oxide synthase activity by preventing electron transfer", Neuropsychobiology, 33, pp.76~79 (1996)
  78. Nel A, "Haloperidol-induced dyskinesia associated with striatal NO synthase inhibition: reversal with olanzapine", Behav Pharmacol, 14, pp.251~255 (2003)
  79. Lau YS, "Elevated neuronal nitric oxide synthase expression in chronic haloperidol-treated rats", Neuropharmacology, 45, pp.986~994 (2003)
  80. Mayer B, "Novel actions of methylene blue", Eur Heart J, 14, pp.22~26 (1993)
  81. Deutsch SI, "Fay-McCarthy M, Rosenberg PB, Fearing K. Methylene blue adjuvant therapy of schizophrenia", Clin Neuropharmacol, 20, pp.357~363 (1997)
  82. Narsapur S, "Methylene blue: a possible treatment for manic depressive psychosis", J Affect Disord, 5, pp.155~161 (1983)
  83. Naylor G, "Possible explanation for therapeutic action of lithium and a possible substitute (methylene blue)", Lancet, 2, pp.1175~1176 (1981)
  84. Moncada S, "Mechanism of action of some inhibitors of endothelium-derived relaxing factor", Proc Natl Acad Sci USA, 통권 : 83, pp.9146~9168 (1986)
  85. Post RM, "Sensitization, kindling, and anticonvulsants in mania", J Clin Psychiatry, 50, pp.23~30 (1989)
  86. Dubovski S, "The calcium second messenger system in bipolar disorders: data supporting new research directions", J Neuropsychiatry Clin Neurosci, 4, pp.3~14 (1992)
  87. Bernstein HG, "Further immunohistochemical evidence for impaired NO signaling in the hypothalamus of depressed patients", Ann NY Acad Sci, 973, pp.91~93 (2002)
  88. Karolewicz B, "Low nNOS protein in the locus coeruleus in major depression", J Neurochem, 91, pp.1057~1066 (2004)
  89. Chrapko WE, "Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder", Biol Psychiatry, 56, pp.129~134 (2004)
  90. Selley ML, "Increased (E)-4-hydroxy-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression", J Affect Disord, 80, pp.249~254 (2004)
  91. Squadrito F, "Food deprivation increases brain nitric oxide synthase and depresses brain serotonin levels in rats", Neuropharmacology, 33, pp.83~86 (1994)
  92. Squadrito F, "Anorectic activity of NG-nitro-L-arginine, an inhibitor of brain nitric oxide synthase, in obese Zucker rats", Eur J Pharmacol, 230, pp.125~128 (1993)
  93. Rebeck GW, "The pattern of NADPHdiaphorase staining, a marker of nitric oxide synthase activity, is altered in the perforant pathway terminal zone in Alzheimer’s disease", Neurosci Lett, 152, pp.165~168 (1993)

관련 논문AI추천

이 간행물의 다른 논문 (4건)